DoseVue NV

Company details

Company name DoseVue NV
Company type Micro Enterprise (less than 10 employees and revenues less than 2 MEUR)
Industry sector Medical
Activity description

DoseVue N.V. was founded in March 2013 by Emiliano D'Agostino and the Belgian Nuclear Research Center (SCK•CEN). DoseVue is the first spin-off company at SCK•CEN, an internationally renowned player in the field of radiation protection and dosimetry research, and one of the most important suppliers of medical radio isotopes worldwide. In the past years DoseVue is developing an entire portfolio of non-invasive and minimally invasive technologies for in-vivo dosimetry and a new product line dedicated to preclinical and clinical quality insurance. Products are already present on the market.

Company website http://www.dosevue.com/

Project information

Technology platform TP-2: Glass and Polymer Speciality Fibers & Fiber Devices
Application domain Biomedical
Project scope

Design and optimisation of a dosimetry platform based on optical fibers for real-time multi-point dose monitoring in patients

ACTPHAST Partners VUB
Project leader Tigran Baghdasaryan
Project start March 2018
Project duration 12 months